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Abstract
Background: Spermatogenesis is an androgen-dependent process, yet the molecular mechanisms of
androgens' actions in testis are poorly understood. Transgenic mice overexpressing rat androgen-binding
protein (ABP) in their testes have reduced levels of intratesticular androgens and, as a result, show a
progressive impairment of spermatogenesis. We used this model to characterize changes in global gene
expression in testis in response to reduced bioavailability of androgens.
Methods: Total RNA was extracted from testes of 30-day old transgenic and wild-type control mice,
converted to cRNA, labeled with biotin, and hybridized to oligonucleotide microarrays. Microarray results
were confirmed by real-time reverse transcription polymerase chain reaction.
Results: Three-hundred-eighty-one genes (3.05% of all transcripts represented on the chips) were up-
regulated and 198 genes (1.59%) were down-regulated by at least a factor of 2 in the androgen-deficient
animals compared to controls. Genes encoding membrane proteins, intracellular signaling molecules,
enzymes, proteins participating in the immune response, and those involved in cytoskeleton organization
were significantly overrepresented in the up-regulated group. Among the down-regulated transcripts,
those coding for extracellular proteins were overrepresented most dramatically, followed by those related
to proteolysis, cell adhesion, immune response, and growth factor, cytokine, and ion channel activities.
Transcripts with the greatest potential impact on cellular activities included several transcription factors,
intracellular signal transducers, secreted signaling molecules and enzymes, and various cell surface
molecules. Major nodes in the up-regulated network were IL-6, AGT, MYC, and A2M, those in the down-
regulated network were IL-2, -4, and -10, MAPK8, SOCS1, and CREB1.
Conclusion: Microarray analysis followed by gene ontology profiling and connectivity analysis identified
several functional groups of genes and individual genes responding to sustained reduction of androgen
levels in the mouse testis. These include genes whose products function as transcription factors, cell
surface molecules including ion channels, extra- and intracellular signaling molecules, and secreted
enzymes with the potential of regulating cell-to-cell attachment. The transcription factors CREB1 (down-
regulated) and MYC (up-regulated) may mediate the most important initial phases of the testicular
response to reduced levels of androgens. These results suggest specific avenues for further research that
will lead to a better understanding of how androgens regulate spermatogenesis.
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Spermatogenesis is an androgen-dependent process, yet
the molecular mechanisms of androgens' actions are
poorly understood. Both testosterone (T) and its active
metabolite dihydrotestosterone (DHT) bind to and acti-
vate the androgen receptor (AR), a member of the family
of ligand-activated transcription factors, coded for by a
single-copy gene on the X chromosome [1]. Although AR
in the testis is present in multiple cellular compartments,
including Sertoli cells (SC), it is not present in germ cells
[2]. It has long been assumed that the actions of andro-
gens on spermatogenesis are mediated largely by SC [3].
Recent studies have demonstrated that SC-selective
knockout of AR results in spermatogenetic arrest in meio-
sis [4-6], confirming that activation of AR in SC is an abso-
lute requirement for androgen maintenance of
spermatogenesis.
Transgenic mice overexpressing rat androgen-binding
protein (ABP) in their testes [7] show progressive abnor-
malities of spermatogenesis leading eventually to infertil-
ity [8]. Detailed analyses of the dynamics of germ cell
proliferation and apoptosis in such animals indicated that
most if not all of the testicular abnormalities may be
explained by reduced bioavailability of androgens in the
testes [9,10]. Direct measurement of testicular total and
free T concentrations, at least up to 60 days of age, support
this hypothesis [11].
The intratubular compartment in the testes of ABP-trans-
genic mice is characterized not only by lower than normal
concentrations of bioavailable androgens but also by
higher than normal concentrations of ABP [8,11].
Although germ cells have been shown to possess receptors
for ABP and germ cells actually internalize ABP in both
normal and transgenic mice [9,12,13], there is no evi-
dence to date to indicate that ABP may have a direct, del-
eterious effect on germ cells in normal or transgenic mice.
Thus, we reasoned that the ABP-transgenic mice may be
used as a model for elucidating the effects of sustained
androgen deficiency on gene expression in the testis, offer-
ing new insights into the molecular mechanisms of the
control of spermatogenesis by androgens. In order to
compare testes with similar cellular composition, we
selected 30-day old mice for these studies.
Materials and methods
Animals
Mice were housed in the animal facility of the University
of North Carolina at Chapel Hill under controlled condi-
tions. Food and water were available ad libitum. The Insti-
tutional Animal Care and Use Committee approved the
protocols used in this study. Transgenic mice overexpress-
ing rat ABP in their testes were developed [7] and were
propagated as described previously [8,9]. Thirty days old
control (wild type, WT, n = 3) and homozygous transgenic
(TG, n = 3) male mice were used for these studies. The ani-
mals were sacrificed by rapid decapitation after a brief
exposure to ether.
Chemicals
All chemicals used in these studies were obtained from
Sigma Chemical Co., St. Louis, MO, unless stated other-
wise.
Target RNA preparation and oligonucleotide array 
expression analysis
Testes were quickly removed, weighed, and placed in ice-
cold TRIZOL (Invitrogen, Carlsbad, CA) solution until
further processing. The two testes from each animal were
combined and total cellular RNA was isolated using the
TRIZOL reagent and purified using RNeasy minicolumns
(Qiagen, Valencia, CA) according to the manufacturers'
instructions. The yield was 150–200 µg of RNA per ani-
mal. The remainder of the procedure was carried out in
UNC's Functional Genomics Core Facility according to
the protocol suggested by Affymetrix (Santa Clara, CA).
The 6 individual samples were submitted in randomly
assigned pairs representing tissues from control (WT) and
test (TG) animals: WT1, TG1, WT2, TG2, WT3, TG3. Seven
µg of total RNA was used to synthesize cDNA. A custom
cDNA kit from Invitrogen was used with a T7-(dT)24
primer for this reaction. Biotinylated cRNA was then gen-
erated from the cDNA using the BioArray High Yield RNA
Transcript Kit. The cRNA was then fragmented in fragmen-
tation buffer (5X fragmentation buffer: 200 mM Tris-ace-
tate, pH8.1, 500 mM KOAc, 150 mM MgOAc) at 94°C for
35 minutes before the chip hybridization. Fifteen µg of
fragmented cRNA was then added to a hybridization cock-
tail (0.05 µg/µl fragmented cRNA, 50 pM control oligonu-
cleotide B2, BioB, BioC, BioD, and cre hybridization
controls, 0.1 mg/ml herring sperm DNA, 0.5 mg/ml
acetylated BSA, 100 mM MES, 1 M [Na+], 20 mM EDTA,
0.01% Tween 20). Ten µg of cRNA was used for hybridi-
zation. Each sample was hybridized to a separate oligonu-
cleotide array (Affymetrix MG-U74Av2) for 16 hours at
45°C in the GeneChip Hybridization Oven 640. The
arrays were washed and stained with R-phycoerythrin
streptavidin in the GeneChip Fluidics Station 400. After
this, the arrays were scanned with a Hewlett Packard
GeneArray Scanner. Affymetrix GeneChip Microarray
Suite (MAS) 5.0 software was used for scanning and basic
analysis. Sample quality was assessed by examination of
3' to 5' intensity ratios of certain genes.
The MG-U74Av2 array contains probes for 12,488 genes
and each gene is represented by multiple (~16) probe
pairs. Each probe pair consists of a perfect match (PM)
and a mismatch (MM) 25-base oligonucleotide. The MM
oligonucleotide is identical in sequence to the PM exceptPage 2 of 14
(page number not for citation purposes)
Reproductive Biology and Endocrinology 2005, 3:70 http://www.rbej.com/content/3/1/70for a single mismatch at the center (13th) base position.
This probe pairing design helps identify and subtract non-
specific hybridization and background signal. Probes rep-
resent unique regions of the gene, allowing for specific
detection of individual gene transcripts, even among
genes from the same family. Each array also contains
probe pairs for controls added to the sample prior to
hybridization as indicated above.
For each probe pair, the MM (non-specific) signal is sub-
tracted from the PM (total) signal. The average of these
differences represents the final "signal" and is reflective of
the level of expression of the gene. The next step is "global
scaling", a form of normalization in which the intensities
of the probe sets are scaled to an average representing all
probe sets, making different arrays of the same experiment
comparable. Finally the MAS 5.0 program creates the
user's file (so-called .CHP file), which can be of two
forms: single array file or comparison file.
For single array analysis, MAS 5.0 calculates statistical sig-
nificance for the average difference between probe pairs
and generates the detection calls Absent, Marginal, or
Present for each gene transcript. A value of p > 0.06 indi-
cates that the gene is not detected at a level significantly
different from background and is thus designated as
Absent; a p value between 0.06 and 0.04 results in a Mar-
ginal call; and a p < 0.04 indicates Present. The comparison
analysis in MAS 5.0 [14] estimates the magnitude and
direction of changes of a transcript when two conditions
are compared directly (experiment versus control). In
order to do this, the software first calculates a probe log
ratio (PLR) for each probe in the probe set by subtracting
the logarithm of the signal in the control array from that
in the experimental array, resulting in 16 PLR values per
gene. The Signal Log Ratio (SLR) is the weighted mean of
these 16 values and is associated with a p value and a
change call of Decreased, Unchanged, or Increased; the
fold change can be calculated as the exponential of the log
ratio. This strategy cancels out differences (variability) due
to different probe binding coefficients and removes much
of the proportional relationship between random error
and signal intensity [15]; it is therefore a more accurate
estimate of differential expression than comparisons
made from single-array analyses where the probe pairs are
first averaged so that only a single pair of values is used for
comparison.
The text files containing signals, p-values, and detection
calls were imported to GeneSpring 6.2 (Silicon Genetics,
Redwood City, CA) software. In GeneSpring, single-array
expression files were normalized to the median of the
same array. All data were filtered so that only signals des-
ignated Present or Marginal (p = 0.06) were included in
further analysis. Lists of genes up- or down-regulated by at
least a factor of 2 in TG mice as compared to WT were con-
structed in GeneSpring using the comparison files. These
two lists were further analyzed using the on-line software
OntoExpress [16,17]. OntoExpress constructs functional
profiles using gene ontology terms for the following cate-
gories: biochemical function, biological process, cellular
role, cellular component, molecular function, and chro-
mosome location. Finally, the lists of up- and down-regu-
lated genes were imported into PathwayAssist (PA;
Stratagene, LaJolla, CA). PA is a bioinformatics software
that combines information from microarray data, scien-
tific literature, and the most important databases to build
pathways and connectivity maps showing how genes, pro-
teins, and small molecules interact to mediate cellular
processes. "Connectivity" (or "controls") is defined in PA
as one of the following 10, user-selectable, functional rela-
tionships: Binding, Regulation, Molecular synthesis,
Molecular transport, Expression, Protein modification,
Cell object control, Chemical reaction, Enzymatic activity,
and Cell process control. At the time of this analysis, the
database contained over 200,000 objects (proteins and
small molecules) and over 100,000 controls (docu-
mented interactions).
Real-time quantitative PCR analysis of representative 
genes
Quantitative real-time RT-PCR was carried out on 8 differ-
ent transcripts in a LightCycler (Roche Applied Science,
Indianapolis, IN) available in the Laboratories for Repro-
ductive Biology at UNC-CH. One µg of total RNA,
extracted from mouse testis and purified as described
above, was reverse transcribed to cDNA with oligo
(dT)12–18 primer to serve as a template. Forward and
reverse primers for the genes of interest were designed and
real-time PCR was run according to the manufacturer's
instructions. Amplification consisted of 40 cycles at 95°C
for 30 sec (denaturation), 55–58°C for 5 sec (annealing),
and 72°C for 10 sec (elongation). SYBR Green I fluores-
cence was used to detect the amplified products. For each
quantification, a standard curve was created using suitably
diluted appropriate cDNA. Following the PCR amplifica-
tion, melting curve analysis was performed on the ampli-
fied product to ensure the accuracy of quantification. In
some cases, this was further confirmed by nucleotide
sequencing.
Results
As shown earlier [9,10], differences in the weight, histo-
logical structure, and cellular composition of the testes of
WT and TG mice involve only a small percentage (<3%)
of the total cell population and these differences in them-
selves are not expected to introduce a major bias in global
gene expression profiles.Page 3 of 14
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6 microarrays are available as supplemental material on
the web site http://www.unc.edu/~petrusz/. The sigle
array files are designated as WT1, WT2, WT3, TG1, TG2,
and TG3; the comparison files are designated as TG1 vs
WT1, TG2 vs WT2, and TG3 vs WT3.
A scatter-plot summary of the microarray expression data
including all genes represented on the MU74Av2 chip
(12,488) is shown in Fig. 1. The consistent location of
average expression values along the first diagonal (the line
for x = y in Fig. 1) indicates that there was no systematic
bias between control and experimental groups. As
expected, a higher variance is seen at lower expression lev-
els than at higher ones. Fig. 1 also indicates that, although
the expression levels of most genes do not differ between
the WT and TG testes, a substantial number of genes are
expressed at an elevated or reduced level in the TG as com-
pared to the WT testes. When the arbitrary difference of 2-
fold (or greater) change was selected, 478 genes were
identified as up-regulated and 311 genes were identified
as down-regulated in the TG vs. the WT testes.
When a filter was applied to select only those genes whose
expression level is significant (p = 0.05) in at least 3 out of
the 6 samples (to allow inclusion of genes that are
expressed below detection limit in one but not in the
other group), a total of 9,810 genes were identified and of
these 471 were up-regulated and 305 were down-regu-
lated in the TG vs. the WT samples.
Plotting the combined (SLR) values from the Affymetrix
comparison files in a frequency distribution graph allows
direct visualization and evaluation of the differential
expression of all genes, as shown in Fig. 2. Fig. 2 uses the
average of SLRs obtained from the 3 comparison files
(TG1 vs. WT1, TG2 vs. WT2, TG3 vs. WT3). On the log2
scale used, 0 represents no change, +1 and -1 represent 2-
fold, +2 and -2 a 4-fold increase and decrease, respectively.
This histogram also reflects the near-symmetrical distribu-
tion of the data around the 0 or "no change" level and
allows easy selection of genes with any desired fold
change value. Because of the more stringent validation cri-
teria used in the calculation of SLR values (see above), this
analysis identified 381 genes (3.05%) that were up-regu-
lated and 198 genes (1.59%) that were down-regulated at
least by a factor of 2, respectively. The two gene lists cre-
ated this way were used for all further analyses presented
Frequency distribution histogram of the average signal log ratios (SLR) from the three comparison filesigur  2
Frequency distribution histogram of the average signal log 
ratios (SLR) from the three comparison files. The SLR 
reflects both the direction and the magnitude of changes in 
gene expression in TG mice compared to WT (for detailed 
explanation, see the text). The vertical scale is a 2-based log 
scale used in computing SLR. On this scale, 0 represents no 
change, +1.0 and -1.0 represent a 2-fold, +2.0 and -2.0 a 4-
fold increase and decrease, respectively. This analysis identi-
fies 381 genes as up-regulated (i.e., those above the horizontal 
line +1.0) and 198 genes as down-regulated (below the hori-
zontal line -1.0).
Two-dimensional scatter-plot of the microarray resultsFigure 1
Two-dimensional scatter-plot of the microarray results. Each 
dot represents average expression values for the same gene 
from control (wild type, WT) animals (horizontal axis) and 
from ABP-transgenic (TG) animals (vertical axis) on a log10 
scale. Genes with similar expression levels appear along the 
first diagonal (the line y=x); genes with expression levels that 
are different in the two groups appear above and below this 
line, respectively; the larger the difference, the farther away 
the point will be from the y = x line. The two parallel green 
lines mark the limits for two-fold differences. This identifies 
478 genes that are up-regulated at least 2-fold and 311 genes 
that are down-regulated at least 2-fold in the TG animals, com-
pared to the WT.Page 4 of 14
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mental material in Additional file 1 and Additional file 2.
The gene lists shown in Additional files 1 and 2, i.e. the
genes differentially expressed between the TG and WT
groups, were subjected to "functional clustering" accord-
ing to the Gene Ontology (GO) classification [18], using
the on-line software OntoExpress [16,17]. The results are
presented in Tables 1 and 2. Only those categories were
included in Tables 1 and 2 that contained at least 3 tran-
scripts. OntoExpress identified 26 GO categories that were
significantly overrepresented in the list of the up-regu-
lated transcripts (Table 1). As seen from Table 1, the larg-
est numbers of transcripts represent those encoding
membrane proteins, components of G-protein-coupled
receptor signaling pathways, catalytic activities, proteins
participating in the immune response, and proteins
related to cytoskeleton organization and biogenesis,
among many others. Interestingly, among the up-regu-
lated transcripts, a significantly greater number than
expected (n = 22, p = 0.00759) were products of genes
located on Chromosome 3. From the list of the down-reg-
ulated transcripts, OntoExpress identified 15 GO catego-
ries that were significantly overrepresented (Table 2). In
this group, transcripts of those genes coding for extracel-
lular proteins were enriched most dramatically, followed
by those related to proteolysis, cell adhesion, immune
response, and growth factor, cytokine, and ion channel
activities.
For the initial interaction analysis, the complete lists of
genes up- or down-regulated in the transgenic mice (Addi-
tional files 1 and 2) were imported to PA as a "new path-
way". The program displays the number of interactions
("connectivity score") known for each gene or protein.
The 20 genes with the highest scores from each list were
selected and are listed in Tables 3 and 4.
PahwayAssist was also used to create functional (interac-
tion) networks of the up- or down-regulated genes. All the
genes belonging to the up-regulated group were dis-
played, all were selected, and the "Build Pathway" com-
mand was used with the option of "Find only direct
interactions between selected nodes" to create a new path-
way (Fig. 3). This network includes 46 proteins connected
by 88 interactions. Four major nodes are evident in this
network: Il-6, AGT, MYC, and A2M, which are connected
to each other and to other proteins with a large number of
interactions; most other proteins have only 1 or 2 interac-
tions within the network. A similar interaction network
Table 1: Gene ontology categories significantly (p < 0.05) overrepresented among the 381 gene transcripts up-regulated in the testis of 
ABP-transgenic mice*
P-value Number of transcripts Percent GO category
0.00708 46 12.07 Membrane
0.00759 22 5.77 Genes located on chromosome 3
0.0449 11 2.89 GPCR signaling pathway
0.03895 11 2.89 Catalytic activity
0.0129 9 2.36 Immune response
0.03625 7 1.84 Peptidase activity
0.03774 7 1.84 Rhodopsin-like receptor activity
0.00798 7 1.84 Cytoskeleton organization and biogenesis
0.00225 6 1.57 Chemotaxis
0.01054 5 1.31 Intermediate filament
0.04126 5 1.31 Serine-type endopeptidase activity
0.00641 5 1.31 Muscle development
0.0152 5 1.31 Lyase activity
1.5E-4 4 1.05 Steroid binding
0.00786 4 1.05 Sodium ion transport
0.02409 4 1.05 Serine-type endopeptidase inhibitor activity
0.00862 3 0.79 Peroxidase activity
<1.0E-5 3 0.79 GP signaling, coupled to IP3 second messenger (phospholipase C activating)
0.04783 3 0.79 Steroid hormone receptor activity
0.03299 3 0.79 Heterotrimeric G-protein complex
0.04461 3 0.79 Ligand-dependent nuclear receptor activity
0.02793 3 0.79 Lipid catabolism
0.03571 3 0.79 Symporter activity
0.00561 3 0.79 Response to oxidative stress
0.03855 3 0.79 Regulation of transcription
4.9E-4 3 0.79 Structural constituent of eye lens
*Categories containing fewer than 3 transcripts were excluded.
Abbreviations: GP: G-protein; GO: Gene ontology; GPCR: G-protein-coupled receptor; IP3: inositol-3-phosphate.Page 5 of 14
(page number not for citation purposes)
Reproductive Biology and Endocrinology 2005, 3:70 http://www.rbej.com/content/3/1/70was created from the list of down-regulated genes (Fig. 4).
Of the proteins in this gene list, 38 were directly con-
nected to each other through 72 "contols" or interactions
(Fig. 4). This network includes several major nodes (Il-2,
-4, and -10, MAPK8, SOCS1, and CREB1). Since up- and
down-regulated proteins can interact with each other, we
have attempted to combine the two groups and carry out
the interaction analysis on the combined list of 579
genes/proteins. The resulting pathway contained 434
nodes and 12,610 interactions and was too large to be
reproduced here.
The results of quantitative PCR analysis carried out on
selected transcripts representing decreased, unchanged,
and increased levels of transcription are presented in
Table 5.
Discussion
The results reported in Table 5 confirm the fundamental
validity of the microarray analysis with the apparent
exception of the SHBG/ABP gene product, for which the
expression ratio is found to be 128.08 by RT-PCR and
only 2.41 by microarray analysis. The reason for this dis-
Table 3: Genes with the highest connectivity scores among all (381) genes up-regulated in the testes of ABP-TG mice.
Name GenBank ID Connectivity score Fold increase Description
IL-6 X54542 969 2.52 Cytokine; extracellular
AGT AF045887 927 2.64 Protease inhibitor; extracellular
MYC L00039 594 2.25 Oncogene, transcription factor; cell cyle, apoptosis
CAT M29394 405 2.19 Peroxidase; intracellular
EGR1 AV369921 323 2.46 Transcription factor; differentiation, mitogenesis
NTF3 X53257 144 2.41 Growth factor; extracellular
A2M AI850558 132 2.14 Protease in hibitor; extracellular
LYZS M21050 132 2.14 Lysozyme; extrecellular
CFTR AV374675 123 3.40 Ion channel (cystic fibrosis transmembrane conductance regulator); plasma 
membrane
SHBG U85644 122 2.41 Androgen-binding protein/ sex hormone binding globulin; extracellular
PGR M68915 123 2.19 Progesterone receptor; transcription factor
HAND2 U43715 109 2.19 Heart and neural crest derivatives expressed transcript 2; transcription 
factor
VDR AW061016 102 2.41 Vitamin D receptor; transcription factor
GDNF AV296394 99 2.52 Growth factor; extracellular
RAD51 AV311591 97 7.64 DNA repair; meiosis
BTK AV227438 91 2.14 Tyrosine kinase; intracellular
MAP2K3 X93150 86 2.41 Signal transduction; intracellular
MME M81591 85 2.00 Metallo-endopeptidase; plasma membrane
CD36 L23108 80 2.05 Collagen type I receptor; cell adhesion, apoptosis; plasma membrane
HSPA8 AV257761 78 2.19 Heat shock protein; chaperone; intracellular
Table 2: Gene ontology categories significantly (p < 0.05) overrepresented among the 198 gene transcripts down-regulated in the 
testis of ABP-transgenic mice*
P-value Number of transcripts Percent GO category
0.00838 37 18.69 Extracellular space
0.00203 10 5.05 Extracellular
0.02622 8 4.04 Proteolysis and peptidolysis
0.04705 7 3.54 Cell adhesion
0.00209 7 3.54 Immune response
0.00622 5 2.53 Growth factor activity
0.00566 5 2.53 Cytokine activity
0.04561 5 2.53 Ion channel activity
0.04894 4 2.02 Rhodopsin-like receptor activity
0.00567 4 2.02 Chymotrypsin activity
0.00567 4 2.02 Hormone activity
0.00752 4 2.02 Trypsin activity
0.00000 3 1.52 Positive regulation of MHC class II biosynthesis
0.0105 3 1.52 Monooxygenase activity
0.00219 3 1.52 Blood coagulation
*Categories containing fewer than 3 transcripts were excluded.Page 6 of 14
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specificity of the microarray analysis compared to the RT-
PCR as used here: the TG mice express an excess of rat
SHBG/ABP and, although the rat and mouse genes are
89% homologous [19], the multiple probes included in
the Affymetrix arrays detect the differences and, as a result,
do not hybridize as efficiently with the rat mRNA. The
primers used for the RT-PCR, on the other hand, do not
distinguish between the two species and reflect, correctly,
the total (both rat and mouse) ABP mRNA present in the
testis. This result is in fact a testimony to the added specif-
icity resulting from the multiple probe set design of the
Affymetrix microarrays. The 128-fold increase is consist-
ent with our previously reported measurements based on
[3H]-dihydrotestosterone-binding activity [8].
The studies reported here establish that in 30-day old
ABP-TG mice there are specific changes in testicular gene
expression manifested by a 2-fold or greater increase in
the transcripts of 381 genes and a 2-fold or greater
decrease in the transcripts of 198 genes, a total of 579
genes or 4.64% of all genes represented on the MU74Av2
array. Based on a search of public databases, the expres-
sion of nearly 50% of these 579 genes has not been
described in testis to date and only a very few have been
described as androgen-regulated. We also report, for the
first time, enriched gene ontology categories and interac-
tive networks of gene products that are co-regulated
(either induced or repressed) in response to increased lev-
els of intratesticular ABP.
Since we have demonstrated that excess production of
ABP in our transgenic animals is associated with normal
or reduced levels of androgens [11], and since ABP-bound
androgens are regarded biologically inactive [20], it is rea-
sonable to conclude that the changes in gene expression
described here reflect a testicular response to a high ABP/
low androgen environment. Furthermore, since there is
no evidence to date that ABP, either at physiological or at
higher than physiological concentrations might have a
direct deleterious effect on the proliferation and/or differ-
entiation of germ cells in the testis, the impaired sperma-
togenesis seen in these animals [8,9] is most likely the
result of reduced availability of androgens and not the
direct effects of excess ABP. Consequently, the ABP-trans-
genic mouse is a suitable model for studying the effects of
chronically reduced levels of androgens on gene expres-
sion in testis. Thirty-day old mice were selected for the
present analysis because our previous studies had shown
that differences in the cellular composition of the testes
between TG and WT were minimal (<3%) at this age. Yet,
since the first wave of spermatogenesis is already well
under way (round spermatids are present in large num-
bers, and a few elongated spermatids just start to appear
[9]), most of the regulatory mechanisms operational in
the adult should already be in place.
The complex molecular events that lead to the decline of
spermatogenesis following withdrawal of androgens in
vivo (for a review, see ref. 3) are believed to be initiated in
SC, a step that is likely to involve transcriptional mecha-
Table 4: Genes with the highest connectivity scores among all (198) genes down-regulated in the testes of ABP-TG mice.
Name GenBank ID Connectivity Score Fold decrease Description
MAPK8 AB005663 1000 2.70 Signal transduction; protein kinase
IL-2 K02292 673 3.73 Cytokine; growth factor; extracellular
IL-4 AA967539 681 2.05 Cytokine; humoral defense; extracellular
IL-10 M37897 427 3.32 Cytokine; immune response; extracellular
HGF X72307 392 2.76 Hepatocyte growth factor; trypsin activity; extracellular
CREB1 X67719 344 2.14 Transcription factor, linked to cAMP signaling
GAST AV062425 267 2.30 Gastrin; extracellular
MMP2 M843224 179 2.25 Matrix metalloprotease; type IV collagenase; extracellular
CD44 U57611 166 2.41 Hyaluronan receptor; cell surface glycoprotein
F10 AF087644 133 2.96 Coagulation factor X; serine protease; extracellular
MPO X15313 129 3.32 Myeloperoxidase; antibacterial defence; extracellular
GHRH M31654 103 2.00 Growth hormone releasing hormone; extracellular
ITIH4 AF023919 91 2.46 Trypsin inhibitor; extracellular
SLC9A U51112 79 2.46 Ion channel; Na+/H+ exchanger; transmembrane protein
GFAP X02801 74 2.14 Intermediate filament/structural protein; intracellular
VWF AI843063 63 2.30 Von Willebrand factor; cell attachment; extracellular
SMARCA-4 AA097203 45 2.25 Transcription factor; chromatin remodeling; nucleus
HCRT AF019566 38 2.46 Precursor of hypocretin neuropeptides; extracellular
GATA2 AV377670 37 3.18 Transcription factor; development; nucleus
NTRK3 AF035400 34 2.76 Cell surface receptor, non-catalytic isoformPage 7 of 14
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generated this way in SC are then greatly amplified (see
below) and subsequently delivered to germ cells either
through SC surface specializations (membrane proteins,
receptors, junctional complexes, ion channels) or via
secreted signaling molecules. One of the difficulties in
Interactive map (pathway) of 46 genes/proteins created in PathwayAssist® from the list of transcripts up-regulated in the testes of ABP-transgenic miceFigure 3
Interactive map (pathway) of 46 genes/proteins created in PathwayAssist® from the list of transcripts up-regulated in the testes 
of ABP-transgenic mice. AGT, A2M, IL-6, and MYC are "nodes" with multiple connections whereas most other components 
have only one or two connections. The symbols along the connecting lines indicate the nature of the interaction (Expression: 
blue square; Regulation: gray square; Molecular transport: gray square with green outline; Protein modification: yellow hexa-
gon; Binding: purple diamond; Promoter binding: green diamond; Molecular synthesis: light blue square with dark blue outline; 
and Chemical reaction: clear square; stimulation or inhibition is indicated by + or - signs within the symbols).Page 8 of 14
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two genes are known to date that are expressed in SC and
respond directly to androgens (i.e., possess androgen
response elements), the homeobox gene PEM [21] and
the protooncogene MYC [22]. Perhaps for this reason, and
because of the very complex cellular interactions required
for normal spermatogenesis [23,24], previous attempts to
identify androgen-regulated gene expression in testis with
traditional methods were largely unsuccessful [3].
The first logical step in analyzing differential gene expres-
sion is to find the genes with significantly increased or
decreased expression in the experimental group compared
to controls [25]. As customary in similar studies, a two-
fold or greater change (decrease or increase) was arbitrar-
ily defined as the "minimum significant change" for the
purposes of the present analysis. (This is not meant to
imply that smaller fold changes may not be biologically
significant.) The use of the combined SLR values instead
Interactive map (pathway) of 38 genes/proteins created in PathwayAssist® from the list of transcripts down-regulated in the testes of ABP-transgenic miceFigure 4
Interactive map (pathway) of 38 genes/proteins created in PathwayAssist® from the list of transcripts down-regulated in the 
testes of ABP-transgenic mice. Major nodes are IL-2, 4, and 10, MAPK8, SOCS1, CD44, and CREB1. For explanation of sym-
bols, see legend to Fig. 3.Page 9 of 14
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itives frequently encountered at low levels of expression in
single-array analysis [15,16].
As described above and reported in Additional Files 1 and
2, the fold change filter identified 381 increased and 198
decreased gene transcripts in the TG samples as compared
to the WT. This simple analysis has thus identified two
groups of genes that are co-expressed and are, therefore, in
some way co-regulated in these samples. It is interesting to
note that, after a reduction of androgen levels, the expres-
sion of a larger number of genes is increased and that of
only a smaller number is decreased. This tendency for up-
regulation after androgen withdrawal is consistent with
the findings of Griswold's group [26] in genetically
hypogonadal mice, in which T treatment generally
repressed, rather than stimulated, gene expression. This
phenomenon may represent a compensatory mechanism
activated in T-deprived Sertoli cells or some of the acti-
vated genes may actually be negative regulators of Sertoli
cell functions required for the support of spermatogene-
sis.
Functional analysis of groups of genes as large as 381 and
198, respectively, is still difficult by the traditional "gene
by gene" approach. Traditional clustering algorithms
available in GeneSpring (dendrograms, K-means, self-
organizing maps, etc.) did not seem to reveal biologically
meaningful clusters of genes in the present study.
The GO annotations [18] together with statistical evalua-
tion of the level of representation of each GO category by
OntoExpress [16,17] provide a standardized, clear, and
effective way of classifying gene expression data into bio-
logically meaningful classes. When the differentially up-
or down-regulated genes (Additional Files 1 and 2) were
subjected to this analysis, several functionally defined
groups were identified (Tables 1 and 2). Prominent
among these are membrane proteins, various groups of
intracellular signaling molecules, proteolytic enzymes,
and proteins related to the immune response and
cytoskeletal organization (up-regulated), and extracellular
structural and messenger molecules and those related to
cell adhesion (down-regulated). Detachment of germ cell
clusters from SC is a known consequence of both experi-
mental withdrawal of testosterone [27] and hypersecre-
tion of ABP [8].
Both differentially expressed (up- or down-regulated)
groups include several ion channels. Among the up-regu-
lated ion channels are several potassium channels (Kcne1,
Irk1, Kcc1), sodium channels (BLINaC, Slc4a4, Ntcp), the
cAMP-regulated chloride channel CFTR, and the water
transporter Aqp4. Seminiferous tubule fluid in normal
rats contains ten times higher potassium but lower
sodium concentrations than blood; the secretion of the
fluid and the maintenance of the ion gradients depend on
SC [28] and are androgen-regulated [29,30]. Among the
down-regulated genes are those coding for calcium entry
channel TRP6, a voltage-gated potassium channel β-subu-
nit KVB1, and the G-protein-coupled inward rectifying
potassium channel 1 (GIRK1). Mutations of the second
subunit of this channel, GIRK2, are responsible for the
weaver phenotype characterized by degeneration of the
granule cells of the cerebellum, testicular germ cells, and
Sertoli cells [31].
Table 5: Comparison of expression ratios of selected genes from testes of ABP-transgenic (TG) and wild type (WT) mice as 
determined by real-time PCR and microarray analysis.
Name and GenBank Accession ID Primers TG/WT ratio
RT-PCR
TG/WT ratio
microarray
Androgen receptor M37890 5' GGC CCC CAT CCA AGA CCT ATC 3'
5' GGC TCG GGG AGG CAG CTG 3'
0.95* 1.00
Aromatase P450 D00659 5' GGG CCC CTC ATT TCC CAT GG 3'
5' CCG GTC CAA ATG CTG CTT GAT G 3'
1.13 1.02
17-beta-hydroxysteroid dehydrogenase 1 AF039299 5' GCT CCT CTG GAA TCG GCA TGC 3'
5' CCA CAC GAC CCT CAG TCA CG 3'
1.39 0.91
GAPDS testis-specific isoform U09964 5'GGA TTT GGA CGC ATT GGT CG 3'
5'GAT CTC AAG GTT GTC CAC AAC 3'
-1.82 -2.08
24 kDa major androgen-regulated protein, arMEP24 
AV381732
5'GAG TCC CCT TGG CCA TTC TG 3'
5'CCT GTG CGA GTC AAT CTG CTC 3'
3.20 3.65
MYC L00039 5'GAT GTG GTG TCT GTG GAG AAG 3'
5'CCG CAC CCC CCT CCA CAA G 3'
2.10 2.25
SHBG/ABP U85644 5' GCC CTG AGA CAC ATT GAC CCT 3'
5' CAG GGC AGG CAG GAG CG 3'
128.08* 2.41
Testis-specific protein U21673 5' GCC AAA CGC ATC AAT CCC CGG 3'
5' GTC ATC AAA CGG AGG TTC CAG G 3'
0.77* 0.93
* Amplified sequence confirmed by nucleotide sequencingPage 10 of 14
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Onto-Express [16,17] (Tables 1 and 2) bring into focus
the biologically important changes within the large
number of unorganized data generated by the microarray
analysis. These results represent a specific combination or
pattern of cellular functions that change in response to a
particular stimulus (in this case, reduction of bioavailable
androgens), ultimately resulting in a particular pheno-
type. Thus, these results are the gene expression profile of that
phenotype.
Most cellular functions are carried out by proteins inter-
acting with each other and with a variety of small mole-
cules. The software PathwayAssist is capable of identifying
such interactions based on evidence available in public
databases. In an attempt to further narrow our focus from
functional groups of genes to individual genes and their
transcripts, we reasoned that proteins with greater
number of interactions must have a greater impact on cel-
lular functions than proteins with lower number of inter-
actions. A similar strategy was used by Yonan et al. [32] to
identify genes or gene variants that may contribute to
autism.
The strategy based on connectivity scores identified a
number of genes as major candidates that may mediate
androgens' actions on spermatogenesis. Among the up-
regulated high-impact genes (Table 3), 7 code for secreted
enzymes or signaling molecules (IL-6, AGT, NTF3, A2M,
LYZS, SHBG, and GDNF), 6 for transcription factors and a
DNA repair molecule (MYC, EGR1, PGR, VDR, HAND2,
RAD51), 3 for cell surface proteins (CFTR, MME, CD36),
2 for intracellular signal transducers (MAP2K3, BTK), and
2 for intracellular proteins related to stress response (CAT,
HSPA8). Only the most important of these genes will be
briefly discussed below.
Among the secreted signaling molecules, IL-6 is produced
in the testis by both SC and Leydig cells in response to a
number of stimuli [33]. Its receptor, gp130, is also
expressed in SC [34] and activation of the receptor results
in STAT-1 and STAT-3 phosphorylation and subsequent
activation of several transcription factors [35]. IL-6 has a
number of effects on seminiferous epithelial function,
including stimulation of transferrin production by SC
[36], and inhibition of meiotic DNA synthesis in pre-lep-
totene spermatocytes [37]. It has been suggested that IL-6
expression is a downstream target for JNK (MAPK8) in
myoblasts [38]. A2M (alpha-2-macroglobulin) is a serum
protein secreted by SC. It is a major nonspecific protease
inhibitor of the seminiferous epithelium, secreted in a
stage-specific manner, and controlled in part by FSH
[23,39]. It also functions as a cytokine binding/transport-
ing molecule [40] and is thus capable of modulating the
actions of proteases and growth factors in the seminifer-
ous epithelium. LYZS encodes lysozyme, whose natural
substrate is the bacterial cell wall peptidoglycan, cleaves
the beta [1-4] glycosidic linkages between N-acetyl-
muramic acid and N-acetylglucosamine. It has been pro-
posed that lysozyme may function as a receptor/binding
protein for N-acetylglucosamine [41]. Through this inter-
action, lysozyme may regulate germ cell-SC attachment
and germ cell survival [42].
MYC, a member of the helix-loop-helix/leucine zipper
superfamily, is expressed during proliferation in a wide
variety of adult tissues including the testis. In transgenic
rats expressing c-myc, spermatogenesis is arrested at the
level of primary spermatocytes and apoptotic DNA-frag-
mentation increases [43]. C-myc is an androgen-regulated
gene expressed in SC [22] and highly expressed c-myc can
repress the activity of a large number of other genes [44].
Increased testicular c-myc mRNA expression was reported
in adult rats treated with the anti-androgen flutamide
[45]. Thus the increased expression of c-myc in the ABP-
TG mice may contribute significantly to the defect in sper-
matogenesis seen in these mice. (It is interesting that the
only other SC gene that responds to androgens directly,
PEM, was not differentially expressed in our samples.)
The CD36 gene product, a membrane-associated glyco-
protein, functions as a receptor for thrombospondin and
type-I collagen and a facilitator for membrane fatty acid
transport. It plays major roles as an adhesion molecule
and as a scavenger receptor implicated in cellular lipid
metabolism and in the phagocytosis of residual bodies
and apoptotic germ cells by SC [46].
Among the 20 down-regulated genes listed in Table 4, as
many as 12 code for secreted signaling molecules. These
include three interleukins (2, 4, and 10), hepatocyte
growth factor, gastrin, a matrix metalloprotease MMP2,
myeloperoxidase, two coagulation factors, VWF and F10,
a trypsin inhibitor (ITIH4), GHRH, and hypocretin, the
precursor protein for the neuropeptides orexin 1 and 2.
One gene (MAPK8) is involved in intracellular signal
transduction, 3 code for transcription factors (CREB1,
SMARCA-4, and GATA2), 3 for cell surface molecules
(CD44, SLC9A, and NTRK3), and one for the intermedi-
ate filament-structural protein GFAP.
Il-2, -4, and -10 are generally proliferation promoting
cytokines, but their site of production and role in testis is
not clear. Il-2 has been described as a potent inhibitor of
Leydig cell steroidogenesis [47]. HGF (hepatocyte growth
factor) is a pleiotropic cytokine apparently produced by
peritubular cells of the testis [48]. Its receptor, c-met, is
expressed in SC. The HGF-c-met system is required for the
formation of seminiferous tubules during development
[49]. HGF can promote cell adhesion by up-regulatingPage 11 of 14
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similar relationship may exist in the testis. The MMP2
gene encodes an enzyme which degrades type IV collagen,
the major structural component of basement membranes.
Both active MMP2 and its precursor have been detected in
SC cultures and their production appears to depend on
FSH [52]. MMP2, together with other proteases and pro-
tease inhibitors, plays an important role in the mainte-
nance and restructuring of SC tight junctions and the
blood-testis barrier, structures whose integrity is indispen-
sable for normal spermatogenesis. MAPK8 (JNK), an
intracellular signal transducer, has the highest connectiv-
ity score among all down-regulated genes. MAPK8 is acti-
vated by various extracellular stimuli and targets specific
transcription factors, thereby mediating immediate-early
gene expression in response to cell stimuli. It is a compo-
nent of the integrin-linked signaling cascade [53]. (C-jun
expression was also reduced in our TG animals albeit only
by a factor of 0.4.)
Among the three down-regulated transcription factors
listed in Table 4, CREB1 is expressed in SC where it is
known to activate a number of genes required for normal
spermatogenesis [e.g., [54,55]]. Since CREB1 is down-reg-
ulated in the ABP-TG mice, its role in mediating the effects
of androgen withdrawal on spermatogenesis in these mice
may be significant. The involvement of MAPK and CREB
in non-traditional, rapid androgen signaling in SC has
recently been demonstrated [56,57]. Although the ABP-
TG mouse as an experimental model does not allow us to
discern rapid effects of androgen withdrawal, it is possible
that the same, cell-surface mediated mechanisms remain
operational even in a chronic androgen-depletion model.
This possibility is reinforced by the large number of signal
transduction-related genes whose expression is up- or
down-regulated in the ABP-TG mice (see Tables 1, 2, 3, 4,
and Figs. 3 and 4).
The interaction networks presented in Figs. 3 and 4 pro-
vide additional insights into the changes in testicular gene
expression resulting from reduced androgen levels in the
testis. Among the major nodes, the transcription factors
CREB1 (down-regulated) and MYC (up-regulated) stand
out representing perhaps the most important initial
phases of the response to reduced androgen levels; next, it
is apparent that paracrine factors, such as the interleukins
2, 4, 6, and 10, angiotensinogen, alpha-2-macroglobulin,
and SOCS1, a negative regulator of cytokine signaling,
play important roles in the response. MAPK8 stands out
among the intracellular signaling molecules as also play-
ing a central role. Figs. 3 and 4 identify 46 and 38 genes
(gene products), respectively, that are not only co-regu-
lated in the ABP-TG mice but are also capable of function-
ally interacting with each other. This conclusion is
reinforced and extended by the results from the combined
analysis of all 579 differentially expressed genes, resulting
in identification of 434 nodes and 12,610 interactions.
The extensive connectivity between these genes indicates
that they indeed form a coherent network that reflects and
determines the differences between the TG and the WT
animals.
Our results suggest a number of important avenues for
future research. These include detailed characterization of
the identified single genes or relatively small groups of
functionally related genes in terms of their involvement in
mediating androgens' actions on spermatogenesis. First, it
will be important to establish which of the implicated
genes are actually expressed in SC. For some of the genes,
this is already known (see above); for others, specific
localization studies targeting their mRNA or protein prod-
ucts may be performed. In-depth analysis of transcription
factors whose expression is significantly affected by
androgen withdrawal appears to be an important first step
in untangling the complex changes we have observed.
Data mining of the extensive interactions among the dif-
ferentially expressed genes is also likely to provide new
functional insights. Whereas our present animal model
represents chronic, ongoing androgen deficiency, it will
be important to conduct acute and time-resolved experi-
ments by artificial depletion of endogenous androgens
followed by restoration of physiological androgen levels
within the testis. Such in vivo manipulations of androgen
status may be followed by using isolated SC as a source of
RNA for microarray studies.
Conclusion
We report a complex pattern of altered gene expression in
mouse testis containing high levels of ABP and low levels
of bioavailable androgens. Gene ontology and connectiv-
ity analyses of the differentially regulated genes have iden-
tified relevant biological processes as well as key
individual genes. They include genes whose products
function as transcription factors, extra- and intracellular
signaling molecules, most prominently cytokines, and
extracellular enzymes with the potential of regulating cell-
to-cell attachment and cytokine transport. One of only
two genes known to be expressed by SC and directly
respond to androgens, MYC, has been identified as a crit-
ical component of the up-regulated network (Fig. 3, Table
2), whereas CREB1, known to be essential for sperma-
togenesis, was down-regulated. Several ion channels,
potential regulators of the extracellular environment
within the seminiferous tubules, have also emerged as
possible targets of androgen action. Identification of
androgens' molecular targets in the testis will lead to bet-
ter understanding of the physiological control of sperma-
togenesis, and potentially to the development of new
therapeutic and contraceptive approaches.Page 12 of 14
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